The increasing incidence of young-onset colorectal cancer: A call to action

Dr. Whitney Jones from the University of Kentucky in Louisville, and Jasmine Greenamyer from the Colon Cancer Alliance in Washington, D.C., discuss the article appearing in the February 2014 issue of Mayo Clinic Proceedings.

Population Screening for Barrett's Esophagus

Dr. Ganapathy A. Prasad, Associate Professor of Medicine in the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, MN, discusses his article appearing in the December 2011 issue of Mayo Clinic Proceedings.

Metabolic Syndrome as a Risk Factor for Barrett's Esophagus

Noting a 2-fold increase in risk of Barrett's Esophagus, Dr. Cadman Leggett, a fellow in gastroenterology at Mayo Clinic in Rochester, MN, discusses his article appearing in the February 2013 issue of Mayo Clinic Proceedings.

Colon cancer study

An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of people with metastatic colorectal cancer, an international phase III clinical trial found.

EUS AIDS diagnosis and treatment of pancreatic cysts

Mark D. Topazian, M.D., of the Division of Gastroenterology and Hepatology at Mayo Clinic in Rochester, Minnesota, discusses endoscopic diagnosis and management of pancreatic cysts, including efforts to refine criteria for resection of ...

Grand Rounds (CME): Overview of the Mayo IBD Translational Research Program

William Faubion, M.D., presents Overview of the Mayo IBD Translational Research Program.